-->

Curaleaf Holdings Stock Net Asset

CURLF Stock  USD 1.44  0.17  13.39%   
Fundamental analysis of Curaleaf Holdings allows traders to better anticipate movements in Curaleaf Holdings' stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Curaleaf Holdings OTC Stock Net Asset Analysis

Curaleaf Holdings' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Curaleaf Holdings Net Asset

    
  3.26 B  
Most of Curaleaf Holdings' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Curaleaf Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, Curaleaf Holdings has a Net Asset of 3.26 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.

Curaleaf Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Curaleaf Holdings' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Curaleaf Holdings could also be used in its relative valuation, which is a method of valuing Curaleaf Holdings by comparing valuation metrics of similar companies.
Curaleaf Holdings is currently under evaluation in net asset category among its peers.

Curaleaf Fundamentals

About Curaleaf Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Curaleaf Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curaleaf Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curaleaf Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Curaleaf OTC Stock

Curaleaf Holdings financial ratios help investors to determine whether Curaleaf OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Curaleaf with respect to the benefits of owning Curaleaf Holdings security.